Jeffrey Rhodes - Afternext Healthtech Director
| AFTRDelisted Stock | USD 10.39 0.01 0.1% |
Insider
Jeffrey Rhodes is Director of Afternext Healthtech Acquisition since 2021.
| Age | 46 |
| Tenure | 3 years |
| Phone | 212 405 8458 |
| Web | https://www.afternexthealthtech.com |
Afternext Healthtech Management Efficiency
Afternext Healthtech's management efficiency ratios could be used to measure how well Afternext Healthtech manages its routine affairs as well as how well it operates its assets and liabilities.Afternext Healthtech Acquisition currently holds 2 M in liabilities. Afternext Healthtech has a current ratio of 0.22, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Afternext Healthtech's use of debt, we should always consider it together with its cash and equity.
AfterNext HealthTech Acquisition Corp. does not have significant operations. The company was incorporated in 2021 and is based in Fort Worth, Texas. Afternext Healthtech operates under Shell Companies classification in the United States and is traded on New York Stock Exchange. Afternext Healthtech Acquisition (AFTR) is traded on New York Stock Exchange in USA and employs 13 people. Management Performance
| Return On Asset | -0.0036 |
Afternext Healthtech Leadership Team
Elected by the shareholders, the Afternext Healthtech's board of directors comprises two types of representatives: Afternext Healthtech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Afternext. The board's role is to monitor Afternext Healthtech's management team and ensure that shareholders' interests are well served. Afternext Healthtech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Afternext Healthtech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| A Breitenstein, Independent Director | ||
| Art Heidrich, Secretary | ||
| Martin CPA, Chief Officer | ||
| Martin Davidson, Chief Financial Officer | ||
| R Wise, Chairman of the Board, Chief Executive Officer | ||
| Bharat Sundaram, Independent Director | ||
| Halsey MBA, CEO Chairman | ||
| Christopher Hunter, Independent Director | ||
| Nehal Raj, Director | ||
| Jeffrey Rhodes, Director | ||
| Bill Miller, Independent Director | ||
| Anthony Colaluca, President Director | ||
| Julie Gerberding, Independent Director |
Afternext Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Afternext Healthtech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Afternext Stock
If you are still planning to invest in Afternext Healthtech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Afternext Healthtech's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |